BEUDAMED
    10 results · 21ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters Regulation: Us FDA ×

    FULL AUTOMATIC (NIBP) BLOOD PRESSURE MONITOR, MODEL HL168KB

    FDA 510(k)
    FDA Class 2 ·Cardiovascular

    Bosworth TruRepair

    FDA UDI
    Harry J Bosworth Company·H6680921631·3 oz Repair Pwd, Clear

    De Soutter Medical

    FDA UDI
    DE SOUTTER MEDICAL LIMITED·05051471123823·K-WIRE - DOUBLE TROCAR 1.6mm DIA x 75mm

    MICROSTREAM EXTERNAL BATTERY CHARGER

    FDA 510(k)
    FDA Class 2 ·Anesthesiology

    POLYTITER SYSTEM

    FDA 510(k)
    FDA Class 2 ·Immunology

    ESSURE

    FDA Adverse Event
    Injury ·CONCEPTUS·Product code HHS·May 1, 2013

    PATIENT DATA MODULE

    FDA Adverse Event
    Malfunction ·GE HEALTHCARE·Product code MHX·April 27, 2011

    EBI VUECATH SPINAL ENDOSCOPIC SYSTEM

    FDA Adverse Event
    Malfunction ·EBI, L.P.·Product code HRX·August 5, 2008

    Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

    FDA Enforcement
    Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012

    CADD-Solis VIP ambulatory Infusion Pumps, Model 2120 (21-2120, 21-2125, and 21-2127) Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

    FDA Enforcement
    Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024